Skip to main content

Table 6 Mean change in utility and score values between baseline and week 4 (available case analysis)

From: Estimating loss in quality of life associated with asthma-related crisis events (ESQUARE): a cohort, observational study

Outcome measure

N

Baseline Mean ± SD

4 weeks Mean ± SD

Mean difference (95% CI)

P-value

EQ-5D-5 L (utility)

71

0.613 ± 0.275

0.740 ± 0.264

0.127 (0.193 to 0.061)

0.000**

VAS (score)

73

47.38 ± 20.08

65.95 ± 21.42

18.56 (23.40 to 13.72)

0.000**

AQLQ (score)

70

3.16 ± 0.980

4.09 ± 1.48

0.929 (1.19 to 0.666)

0.000**

AQL-5D (utility)

69

0.589 ± 0.126

0.687 ± 0.174

0.099 (0.134 to 0.063)

0.000**

TTO (utility)

87

0.650 ± 0.278

0.820 ± 0.264

0.170 (0.243 to 0.097)

0.000**

  1. Wilcoxon signed-rank test
  2. **p-value < 0.01 therefore statistically significant at the 1% level